Latest Close
$50.36
News
CRSP
CRISPR Therapeutics AG News
This news view pulls recent coverage and headlines tied to CRSP.
1y Change
$13.50 (+36.63%)
Market Cap
$4.86B
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
Assessing CRISPR Therapeutics (CRSP) Valuation After Narrower Q1 2026 Loss And Pipeline Progress
Simply Wall St. • May 24, 2026
Read articleCRISPR Therapeutics AG (CRSP) Reports Q1 2026 Results
Insider Monkey • May 23, 2026
Read article[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire • May 21, 2026
Read articleCan Intellia's Pipeline Push Drive Long-Term Growth Amid Rivalry?
Zacks • May 19, 2026
Read articleCRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
Zacks • May 19, 2026
Read articleCRISPR Therapeutics Enters Second Phase As CASGEVY Uptake And Data Build
Simply Wall St. • May 18, 2026
Read article